Aragen Life Sciences is set to fortify its presence in Telangana through a substantial investment of Rs 2,000 crore, anticipating the creation of 1,500 job opportunities. Over the next five years, the company aims to expand its operations, focusing on drug discovery, development, and manufacturing to cater to the global life sciences industry.
This significant investment will catalyze the enhancement of the existing facility in Mallapur, Hyderabad, a city that currently supports over 1,000 global innovators in their quest to discover and develop novel drugs and devices. The strategic announcement positions Hyderabad as a key hub for drug discovery and development, further elevating its status as a renowned center for Contract Research Organisations (CROs).
This initiative aligns with the government's commitment to fostering an advanced ecosystem, robust infrastructure, and showcasing a talented workforce, thereby stimulating innovation and economic growth.
News by Rahul Yelligetti